Creative Planning Decreases Position in Chemed Corporation $CHE

Creative Planning lowered its stake in shares of Chemed Corporation (NYSE:CHE) by 4.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,675 shares of the company’s stock after selling 120 shares during the quarter. Creative Planning’s holdings in Chemed were worth $1,302,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Avantax Advisory Services Inc. increased its holdings in Chemed by 6.5% during the 1st quarter. Avantax Advisory Services Inc. now owns 1,442 shares of the company’s stock worth $887,000 after purchasing an additional 88 shares during the period. Cetera Investment Advisers boosted its stake in shares of Chemed by 6.2% in the 1st quarter. Cetera Investment Advisers now owns 1,715 shares of the company’s stock valued at $1,056,000 after buying an additional 100 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Chemed by 4.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,550 shares of the company’s stock worth $2,184,000 after buying an additional 144 shares in the last quarter. LPL Financial LLC increased its stake in shares of Chemed by 12.7% during the first quarter. LPL Financial LLC now owns 10,527 shares of the company’s stock worth $6,477,000 after buying an additional 1,185 shares during the period. Finally, Mackenzie Financial Corp increased its stake in shares of Chemed by 1.4% during the first quarter. Mackenzie Financial Corp now owns 4,694 shares of the company’s stock worth $2,888,000 after buying an additional 65 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Price Performance

NYSE CHE opened at $439.19 on Friday. The firm’s fifty day moving average price is $440.55 and its 200 day moving average price is $474.60. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The company has a market capitalization of $6.22 billion, a price-to-earnings ratio of 23.23, a price-to-earnings-growth ratio of 2.69 and a beta of 0.43.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). The company had revenue of $624.90 million during the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. Chemed’s revenue was up 3.1% on a year-over-year basis. During the same period last year, the firm earned $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, sell-side analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Monday, November 17th will be given a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is 12.69%.

Analysts Set New Price Targets

CHE has been the subject of several analyst reports. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Royal Bank Of Canada dropped their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Finally, Bank of America decreased their price target on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $574.25.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, September 26th. The stock was sold at an average price of $461.28, for a total value of $1,383,840.00. Following the completion of the sale, the chief executive officer owned 96,197 shares in the company, valued at approximately $44,373,752.16. The trade was a 3.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 150 shares of the stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the sale, the director directly owned 3,397 shares of the company’s stock, valued at $1,574,135.83. The trade was a 4.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 5,150 shares of company stock worth $2,328,449. 3.29% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.